0 Commentaires
0 Parts
445 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Reels
-
Blogs
-
Offres
-
Emplois
-
Connectez-vous pour aimer, partager et commenter!
-
From Patent Expiry to Generic Competition: Analyzing the Immediate and Long-Term Impact on Apixaban Market Pricing and AccessThe Apixaban Market’s current momentum is significantly influenced by its robust adoption within the treatment and prevention of venous thromboembolism (VTE), which encompasses deep vein thrombosis (DVT) and pulmonary embolism (PE). While initially gaining prominence for stroke prevention in non-valvular atrial fibrillation (NVAF), the therapy's application in VTE management represents a...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Global Health Policy and Coagulation: Analyzing the Apixaban Market Global Outlook for the Next DecadeGlobal health policy is increasingly focused on the prevention of non-communicable diseases, with stroke and heart disease at the top of the priority list. International organizations are working to standardize the treatment of conditions like atrial fibrillation across different countries to ensure a high level of care for all patients. This involves the creation of unified clinical guidelines...0 Commentaires 0 Parts 731 Vue 0 Aperçu
-
Managing Anticoagulation in Patients with Chronic Kidney Disease: A Critical Industry SegmentPatients with chronic kidney disease (CKD) present a unique challenge in anticoagulation therapy because many medications are cleared by the kidneys. Use cases for Factor Xa inhibitors in this population require careful dosing adjustments to avoid over-accumulation and the subsequent risk of bleeding. This industry segment is particularly critical as CKD patients often have a high prevalence of...0 Commentaires 0 Parts 855 Vue 0 Aperçu